Ulo, Baby Girl N.
HRN: 20-78-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2022
CEFOTAXIME 500MG (VIAL)
04/11/2022
04/17/2022
IV
52
Q8
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose 1.2kg-2kg <7days: 50mg/kg Q12h= 77mg Q12h
Final appropriateness: Yes
Overall appropriateness: Yes